ロード中...
Identification of Trypanosoma cruzi Growth Inhibitors with Activity In Vivo within a Collection of Licensed Drugs
Chagas disease, caused by the parasite Trypanosoma cruzi (T. cruzi), affects more than six million people worldwide, with its greatest burden in Latin America. Available treatments present frequent toxicity and variable efficacy at the chronic phase of the infection, when the disease is usually diag...
保存先:
| 出版年: | Microorganisms |
|---|---|
| 主要な著者: | , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
MDPI
2021
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7920067/ https://ncbi.nlm.nih.gov/pubmed/33669310 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/microorganisms9020406 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|